Stocks in play: Microbix Biosystems Inc.

Announces that, on behalf of Santina Castriciano of Copan Italia S.p.A. and in collaboration with Victorian Cytology Service of the Australian Centre for the Prevention of Cervical Cancer (VCS Pathology), it will present results of novel methods to support diagnostic accuracy and whole-process workflow validation of cervical cancer screening tests on self-collected patient specimens. The poster presentation will be made at the 12th European Meeting on Molecular Diagnostics taking place in Noordwijk, Netherlands from October 12 to 14. Microbix Biosystems Inc. shares T.MBX are trading down $0.01 at $0.50.

Read:

• Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America

• Fresher, Healthier Food Options Coming Soon to an Airplane Tray Near You

• Airline Industry Wooing Back Customers with Enhanced, Healthier Menu Options

• Vegetarian and Vegan Fliers Winning Important Battle Over In-Flight Menu Options

• Mega Grocery Store Chains Listening to Customers’ Demands for Nutritious, Clean-Label Foods